Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.

Catania MG, Mischel PS, Vinters HV.

J Neuropathol Exp Neurol. 2001 Jul;60(7):711-23.

PMID:
11444800
2.

The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.

Rosner M, Hanneder M, Siegel N, Valli A, Hengstschläger M.

Mutat Res. 2008 Mar-Apr;658(3):234-46. doi: 10.1016/j.mrrev.2008.01.001. Epub 2008 Jan 12. Review.

PMID:
18291711
3.

Tuberous sclerosis as an underlying basis for infantile spasm.

Yeung RS.

Int Rev Neurobiol. 2002;49:315-32. Review.

PMID:
12040899
4.

Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.

Nellist M, Goedbloed MA, Halley DJ.

Biochem Soc Trans. 2003 Jun;31(Pt 3):587-91. Review.

PMID:
12773161
5.

Tuberous sclerosis complex: genetics to pathogenesis.

Narayanan V.

Pediatr Neurol. 2003 Nov;29(5):404-9. Review.

PMID:
14684235
6.

The tuberous sclerosis complex genes in tumor development.

Mak BC, Yeung RS.

Cancer Invest. 2004;22(4):588-603. Review.

PMID:
15565817
7.

Aspects of tuberous sclerosis complex (TSC) protein function in the brain.

Ramesh V.

Biochem Soc Trans. 2003 Jun;31(Pt 3):579-83. Review.

PMID:
12773159
8.

The cell cycle and tuberous sclerosis.

Hengstschläger M, Rosner M.

Prog Cell Cycle Res. 2003;5:43-8. Review.

PMID:
14593699
9.

Tuberous sclerosis gene products in proliferation control.

Hengstschläger M, Rodman DM, Miloloza A, Hengstschläger-Ottnad E, Rosner M, Kubista M.

Mutat Res. 2001 Jul;488(3):233-9. Review.

PMID:
11397651
10.

Proteins interacting with the tuberous sclerosis gene products.

Rosner M, Freilinger A, Hengstschläger M.

Amino Acids. 2004 Oct;27(2):119-28. Epub 2004 Sep 7. Review.

PMID:
15351877
11.

The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.

Rosner M, Freilinger A, Hengstschläger M.

Mutat Res. 2006 Sep;613(1):10-6. Epub 2006 May 18. Review.

PMID:
16713332
12.

Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.

Mizuguchi M.

Congenit Anom (Kyoto). 2007 Mar;47(1):2-8. Review.

PMID:
17300684
13.

Tuberous sclerosis-related gene expression in normal and dysplastic brain.

Vinters HV, Kerfoot C, Catania M, Emelin JK, Roper SN, DeClue JE.

Epilepsy Res. 1998 Sep;32(1-2):12-23. Review.

PMID:
9761305
14.

Tumour suppressors hamartin and tuberin: intracellular signalling.

Krymskaya VP.

Cell Signal. 2003 Aug;15(8):729-39. Review.

PMID:
12781866
15.

Two distinct controls of mitotic cdk1/cyclin B1 activity requisite for cell growth prior to cell division.

Miyazaki T, Arai S.

Cell Cycle. 2007 Jun 15;6(12):1419-25. Epub 2007 May 7. Review.

PMID:
17592253
16.

Translational control during mitosis.

Le Breton M, Cormier P, Bellé R, Mulner-Lorillon O, Morales J.

Biochimie. 2005 Sep-Oct;87(9-10):805-11. Review.

PMID:
15951098
17.

Hamartin and tuberin modulate gene transcription via beta-catenin.

Jozwiak J, Wlodarski P.

J Neurooncol. 2006 Sep;79(3):229-34. Epub 2006 Mar 22. Review.

PMID:
16552619
18.

Cyclin B1 and CDK1: nuclear localization and upstream regulators.

Porter LA, Donoghue DJ.

Prog Cell Cycle Res. 2003;5:335-47. Review.

PMID:
14593728
19.

The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.

Nobukini T, Thomas G.

Novartis Found Symp. 2004;262:148-54; discussion 154-9, 265-8. Review.

PMID:
15562827
20.

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.

Astrinidis A, Henske EP.

Oncogene. 2005 Nov 14;24(50):7475-81. Review.

PMID:
16288294

Supplemental Content

Support Center